Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113480393B reveals a novel Ni-Pd tandem catalytic method using organoantimony compounds for high-yield synthesis of complex pharmaceutical intermediates with reduced costs.
Patent CN101328147A reveals a cost-effective Raney Nickel catalyzed route for Isopropylpyrazolone, offering significant supply chain advantages for API manufacturers.
Patent CN115417782A reveals a green nickel-catalyzed chain walking method for olefin reduction, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN105968068B reveals a mild nickel-catalyzed cyclization method offering significant cost reduction and supply chain reliability for high-purity heterocyclic intermediates.
Novel hydrocyanation process using nickel catalyst enhances purity and yield for nitrile compounds, offering cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Patent CN113024340B reveals nickel catalyzed water hydrogen source method. Offers cost reduction and safety for pharmaceutical intermediate manufacturing supply chains.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Patent CN117383996B reveals selective deuteration method. Offers high yield and simplified supply chain for pharmaceutical intermediate manufacturing.
Patent CN113461597A reveals a cost-effective photoredox/Ni dual catalytic route for nilapanib intermediates, offering significant supply chain stability and reduced manufacturing costs.
Novel Raney Nickel catalyzed route for ertapenem sodium salt offering high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN110734378B reveals a mild Ni-catalyzed method for high-ee chiral allylamines. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel nickel-copper catalytic synthesis offers high yield and scalability for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Patent CN111482178A details a continuous fixed-bed process for chloroquine intermediates using supported nano-nickel, offering high purity and reduced environmental impact for reliable supply chains.
Patent CN108002966B details a safe Ni(II) catalyzed cross-coupling method. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Novel Ni-catalyzed photochemical synthesis offers cost reduction and high enantioselectivity for pharmaceutical intermediates manufacturing.
Patent CN105503767B reveals a novel catalytic method for oxazole ketone compounds. Achieves high yield and purity for reliable pharmaceutical intermediates supply chains.
Novel patent CN104725335B details high-purity Escitalopram Hydrobromide synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Novel amorphous nickel alloy catalysis for m-(β-hydroxyethylsulfone) aniline production offers high yield, reduced pollution, and extended catalyst life for dye manufacturers.
Patent CN115850111A details a nickel-catalyzed migration defluorination allylation. This method offers cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.